Annual report pursuant to Section 13 and 15(d)

Net income (loss) per share

v3.23.1
Net income (loss) per share
12 Months Ended
Dec. 31, 2022
Net income (loss) per share [Abstract]  
Net income (loss) per share
11.
Net income (loss) per share
 
Basic income (loss) per share of common stock is computed by dividing net income (loss) by the weighted average number of shares of common stock outstanding during the period.  Diluted earnings or loss per share of common stock is computed similarly to basic earnings or loss per share except the weighted average shares outstanding are increased to include additional shares from the assumed exercise of any common stock equivalents, if dilutive. The Company’s warrants, stock options and restricted stock awards, while outstanding, are considered common stock equivalents for this purpose. Diluted earnings is computed utilizing the treasury method for the warrants, stock options and restricted stock. Incremental common stock equivalents that were antidilutive were excluded in calculating diluted income per share.  For the year ended December 31, 2021, no common stock equivalents were included in the diluted loss per share because such inclusion would be anti-dilutive given the net loss reported for the prior year period.


The following table presents the computation of weighted average common shares considered in the computation of diluted net income (loss) per share:

     2022     2021
 
Denominator (weighted average shares)
   
     
 
Basic common shares outstanding
 

19,931,080
   

14,852,745
 
Dilutive stock options
   
589,165
     
 
Dilutive warrants
   
76,967
     
 
Diluted common shares outstanding
   
20,597,212
     
14,852,745
 


The following potential common shares were not considered in the computation of diluted net income (loss) per share as their effect would have been anti-dilutive for the year end periods presented below:

   
2022
   
2021
 
Series A, Series B and RDO warrants
   
7,145,201
      7,282,999  
Stock options
   
2,346,879
     
2,096,836
 
Restricted stock awards including pending issuances of stock for services
   
     
6,970
 
Former Rexahn warrants
   
60,713
      66,538  
Former Rexahn options
   
      82